About Our Attorneys View All

Jeannette V. Filippone

Jeannette V. Filippone
Senior Counsel

(t) 619.238.4852
(f) 619.615.7952

Ms. Filippone provides strategic, client-focused legal advice and services to companies in a wide variety of industries, including life sciences, technology, software, services and consumer products.  She specializes in business transactions, business formation and planning, contract drafting and review, intellectual property licensing, federal and state securities law compliance and corporate governance matters.  She has provided legal services in connection with mergers and acquisitions and private and public securities offerings for companies in a wide variety of industries with transaction values ranging from the very small to nearly $4 billion. She has significant expertise in federal securities law compliance, periodic reporting requirements under federal securities laws and advising boards of directors on corporate governance matters.

Prior to joining the firm, Ms. Filippone was an attorney in the corporate group of a leading international law firm and had her own private law practice specializing in business law and transactional matters.  She also served as general counsel and corporate secretary of a Nasdaq-listed specialty pharmaceutical company.  Prior to embarking on her legal career, Ms. Filippone worked in the securities industry, where she held FINRA Series 7, 63 and 24 licenses.

  • Advises clients on equity and debt financing transactions
  • Represents clients in mergers and acquisitions, joint ventures and other strategic transactions
  • Negotiates and drafts agreements related to intellectual property licensing, including technology transfer, clinical trial, collaboration, evaluation, material transfer and professional services agreements
  • Assists clients with federal and state securities law compliance and filings, including preparing and reviewing filings with the Securities and Exchange Commission
  • Has served as acting general counsel for clients, including a privately held life science company and a privately held consumer products company
  • University of San Diego School of Law (J.D., Magna Cum Laude, Order of the Coif)
  • University of California, San Diego (M.A.)
  • University of Massachusetts (B.A., Summa Cum Laude)
  • Revisiting Your Corporate Bylaws – Now’s the Time to Address the Changing Landscape, CORPORATE GOVERNANCE ADVISOR (January/February 2011)
  • Contributing author, the Morrison & Foerster LLP 2011 Proxy Season Field Guide and 2012 Proxy Season Field Guide
  • Contributing author, Fiduciary Duties and Other Responsibilities of Officers and Directors (2008, R.R. Donnelley Capital Markets)
  • Clarity and Legal Certainty?:  The Regulation of OTC Derivatives After Caiola v. Citibank, FUTURES & DERIVATIVES LAW REPORT (March 2003), at 7
  • Clearer Skies for Investors:  Clearing Firm Liability Under the Uniform Securities Act, 39 SAN DIEGO LAW REVIEW 1327 (2002)